RESTRICTION FRAGMENT LENGTH POLYMORPHISMS IN NORMAL AND NEOPLASTIC TISSUES
正常和肿瘤组织中的限制性片段长度多态性
基本信息
- 批准号:6100918
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The major goal of this research project is to identify and characterize
genes involved in the pathogenesis of human kidney cancer. Our major
accomplishments this year are:
1. We demonstrated that mutations in the MET proto- oncogene are
responsible for a recently recognized inherited form of kidney cancer,
hereditary papillary renal carcinoma (HPCR). In contrast to our previous
studies with the von Hippel-Lindau disease gene, mutations in the MET
proto-oncogene were all missense, and were located in the catalytic
domain of the protein. Mutations in the MET proto-oncogene were detected
in 6/7 HPRC families, and in a subset of sporadic papillary renal
carcinomas.
2. We demonstrated that the mutations in MET produced a gain-of-
function. The mutations in MET detected in patients with HPRC and
sporadic tumors produced malignant transformation of NIH 3T3 cells.
Constitutive phosphorylation of the MET protein was demonstrated in
mouse cells transfected with mutant MET genes.
3. Some of the mutations detected in MET were located in residues
homologous to those mutated in other receptor tyrosine kinases, RET and
KIT. These results suggest that we have identified residues of the
catalytic domain common to several receptor tyrosine kinases that in
mutant form produce disease.
4. We have identified another distinct inherited form of renal
neoplasia. So far, we have identified 5 families with multiple members
affected with renal oncocytoma. Affected individuals have multiple,
bilateral renal oncocytomas.
这个研究项目的主要目标是识别和表征
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
B ZBAR其他文献
B ZBAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('B ZBAR', 18)}}的其他基金
RESTRICTION FRAGMENT LENGTH POLYMORPHISMS IN NORMAL AND NEOPLASTIC TISSUES
正常和肿瘤组织中的限制性片段长度多态性
- 批准号:
5200958 - 财政年份:
- 资助金额:
-- - 项目类别:
RESTRICTION FRAGMENT LENGTH POLYMORPHISMS IN NORMAL AND NEOPLASTIC TISSUES
正常和肿瘤组织中的限制性片段长度多态性
- 批准号:
3752045 - 财政年份:
- 资助金额:
-- - 项目类别:
RESTRICTION FRAGMENT LENGTH POLYMORPHISMS IN NORMAL AND NEOPLASTIC TISSUES
正常和肿瘤组织中的限制性片段长度多态性
- 批准号:
3774332 - 财政年份:
- 资助金额:
-- - 项目类别:
PREPARATION OF A HIGH RESOLUTION GENETIC MAP OF HUMAN CHROMOSOME 3
人类 3 号染色体高分辨率遗传图谱的制备
- 批准号:
3796481 - 财政年份:
- 资助金额:
-- - 项目类别:
RESTRICTION FRAGMENT LENGTH POLYMORPHISMS IN NORMAL AND NEOPLASTIC TISSUES
正常和肿瘤组织中的限制性片段长度多态性
- 批准号:
3808537 - 财政年份:
- 资助金额:
-- - 项目类别:
RESTRICTION FRAGMENT LENGTH POLYMORPHISMS IN NORMAL AND NEOPLASTIC HUMAN TISSUES
正常和肿瘤人体组织中的限制性片段长度多态性
- 批准号:
3813381 - 财政年份:
- 资助金额:
-- - 项目类别:
RESTRICTION FRAGMENT LENGTH POLYMORPHISMS IN NORMAL AND NEOPLASTIC TISSUES
正常和肿瘤组织中的限制性片段长度多态性
- 批准号:
6161018 - 财政年份:
- 资助金额:
-- - 项目类别:
MECHANISM OF DELAYED HYPERSENSITIVITY AND TUMOR GRAFT REJECTION
迟发型超敏反应与肿瘤移植排斥的机制
- 批准号:
3939310 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




